Practical guidelines for treating inflammatory bowel disease safely with anti-tumour necrosis factor therapy in Australia

Absence of Infliximab in Infants and Breast Milk From Nursing Mothers Receiving Therapy for Crohnʼs Disease Before and After Delivery

(2009) Sunanda Kane et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Do Tumor Necrosis Factor Inhibitors Cause Malformations in Humans?

(2009) G. KOREN et al.   JOURNAL OF RHEUMATOLOGY

A Safety Assessment of Tumor Necrosis Factor Antagonists During Pregnancy: A Review of the Food and Drug Administration Database

(2009) J. D. CARTER et al.   JOURNAL OF RHEUMATOLOGY

Mathematical modeling of the cause of tuberculosis during tumor necrosis factor blockade

(2008) Robert S. Wallis   ARTHRITIS AND RHEUMATISM

970 Risk of Lymphoma Associated with Anti-TNF Agents for the Treatment of Crohn's Disease: A Meta-Analysis

(2008) Corey A. Siegel et al.   GASTROENTEROLOGY

Withdrawal of Immunosuppression in Crohn's Disease Treated With Scheduled Infliximab Maintenance: A Randomized Trial

(2008) Gert Van Assche et al.   GASTROENTEROLOGY

Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease

(2008) Murat Toruner et al.   GASTROENTEROLOGY

Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection

(2008) Miguel Regueiro et al.   GASTROENTEROLOGY

Hepatosplenic T cell lymphoma in inflammatory bowel disease

(2008) M. Shale et al.   GUT

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

(2008) Geert D'Haens et al.   LANCET

Resolution of Non–Small-Cell Lung Cancer after Withdrawal of Anti-TNF Therapy

(2008) Charles W. Lees et al.   NEW ENGLAND JOURNAL OF MEDICINE